| En route towards European clinical breakpoints for veterinary antimicrobial susceptibility testing: a position paper explaining the VetCAST approach PL Toutain, A Bousquet-Mélou, P Damborg, AA Ferran, D Mevius, ... Frontiers in microbiology 8, 2344, 2017 | 169 | 2017 |
| Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats PVM Steagall, L Pelligand, T Giordano, C Auberger, JW Sear, SPL Luna, ... Veterinary Anaesthesia and Analgesia 40 (1), 83-95, 2013 | 96 | 2013 |
| The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal PL Toutain, L Pelligand, P Lees, A Bousquet‐Mélou, AA Ferran, ... Journal of veterinary pharmacology and therapeutics 44 (2), 172-200, 2021 | 82 | 2021 |
| Veterinary medicine needs new green antimicrobial drugs PL Toutain, AA Ferran, A Bousquet-Melou, L Pelligand, P Lees Frontiers in microbiology 7, 1196, 2016 | 80 | 2016 |
| A history of antimicrobial drugs in animals: Evolution and revolution P Lees, L Pelligand, E Giraud, PL Toutain Journal of Veterinary Pharmacology and Therapeutics 44 (2), 137-171, 2021 | 73 | 2021 |
| Nausea: current knowledge of mechanisms, measurement and clinical impact H Kenward, L Pelligand, K Savary-Bataille, J Elliott The Veterinary Journal 203 (1), 36-43, 2015 | 73 | 2015 |
| Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics C Bon, PL Toutain, D Concordet, R Gehring, T Martin‐Jimenez, J Smith, ... Journal of veterinary pharmacology and therapeutics 41 (2), 171-183, 2018 | 70 | 2018 |
| Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf PL Toutain, T Potter, L Pelligand, M Lacroix, J Illambas, P Lees Journal of veterinary pharmacology and therapeutics 40 (1), 16-27, 2017 | 64 | 2017 |
| Pharmacokinetic–pharmacodynamic integration and modelling of florfenicol in calves P Sidhu, A Rassouli, J Illambas, T Potter, L Pelligand, A Rycroft, P Lees Journal of veterinary pharmacology and therapeutics 37 (3), 231-242, 2014 | 63 | 2014 |
| Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study H Kenward, J Elliott, T Lee, L Pelligand BMC Veterinary Research 13, 1-12, 2017 | 62 | 2017 |
| Side effects to systemic glucocorticoid therapy in dogs under primary veterinary care in the UK DA Elkholly, DC Brodbelt, DB Church, L Pelligand, K Mwacalimba, ... Frontiers in veterinary science 7, 515, 2020 | 56 | 2020 |
| A multicenter randomized controlled trial of medium‐chain triglyceride dietary supplementation on epilepsy in dogs BA Berk, TH Law, RMA Packer, A Wessmann, A Bathen‐Nöthen, ... Journal of veterinary internal medicine 34 (3), 1248-1259, 2020 | 55 | 2020 |
| Evaluation of the dynamic predictors of fluid responsiveness in dogs receiving goal-directed fluid therapy MJ Drozdzynska, YM Chang, G Stanzani, L Pelligand Veterinary Anaesthesia and Analgesia 45 (1), 22-30, 2018 | 51 | 2018 |
| Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida L Dorey, L Pelligand, Z Cheng, P Lees PLoS One 12 (5), e0177568, 2017 | 48 | 2017 |
| Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats GM Doodnaught, BP Monteiro, J Benito, D Edge, F Beaudry, L Pelligand, ... PLoS One 12 (4), e0176443, 2017 | 47 | 2017 |
| Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation L Pelligand, JN King, PL Toutain, J Elliott, P Lees Journal of Veterinary Pharmacology and Therapeutics 35 (1), 19-32, 2012 | 45 | 2012 |
| Relationship between serum iohexol clearance, serum SDMA concentration, and serum creatinine concentration in non‐azotemic dogs M McKenna, L Pelligand, J Elliott, D Cotter, R Jepson Journal of veterinary internal medicine 34 (1), 186-194, 2020 | 43 | 2020 |
| Neutrophil gelatinase‐associated lipocalin in dogs with sepsis undergoing emergency laparotomy: a prospective case–control study S Cortellini, L Pelligand, H Syme, YM Chang, S Adamantos Journal of veterinary internal medicine 29 (6), 1595-1602, 2015 | 43 | 2015 |
| Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida T Potter, J Illambas, L Pelligand, A Rycroft, P Lees The Veterinary Journal 195 (1), 53-58, 2013 | 43 | 2013 |
| Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting Z Sadouki, TD McHugh, R Aarnoutse, J Ortiz Canseco, C Darlow, W Hope, ... Journal of Antimicrobial Chemotherapy 76 (9), 2252-2259, 2021 | 42 | 2021 |
Peter Leesprofessor of veterinary pharmacologyVerified email at rvc.ac.uk
